These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17644216)

  • 21. Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship.
    Völgyi G; Baka E; Box KJ; Comer JE; Takács-Novák K
    Anal Chim Acta; 2010 Jul; 673(1):40-6. PubMed ID: 20630176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interlaboratory study of log P determination by shake-flask and potentiometric methods.
    Takács-Novák K; Avdeef A
    J Pharm Biomed Anal; 1996 Aug; 14(11):1405-13. PubMed ID: 8877846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts.
    He Y; Ho C; Yang D; Chen J; Orton E
    J Pharm Sci; 2017 May; 106(5):1190-1196. PubMed ID: 28153596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miniature device for aqueous and non-aqueous solubility measurements during drug discovery.
    Chen XQ; Venkatesh S
    Pharm Res; 2004 Oct; 21(10):1758-61. PubMed ID: 15553219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between the release of soluble drugs from HPMC matrices and the physicochemical properties of drugs.
    Fu XC; Liang WQ; Ma WX
    Pharmazie; 2003 Mar; 58(3):221-2. PubMed ID: 12685821
    [No Abstract]   [Full Text] [Related]  

  • 28. pH-metric log P. 4. Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values.
    Slater B; McCormack A; Avdeef A; Comer JE
    J Pharm Sci; 1994 Sep; 83(9):1280-3. PubMed ID: 7830244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated potentiometric procedure for studying dissolution kinetics acidic drugs under sink conditions.
    Underwood FL; Cadwallader DE
    J Pharm Sci; 1978 Aug; 67(8):1163-7. PubMed ID: 27630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of liposome partitioning of ionizable drugs by titration.
    Balon K; Riebesehl BU; Müller BW
    J Pharm Sci; 1999 Aug; 88(8):802-6. PubMed ID: 10430546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrophotometric pKa determination of ionizable pharmaceuticals: Resolution of molecules with weak pH-dependent spectral shift.
    Dohoda D; Tsinman K; Tsinman O; Wang H; Tam KY
    J Pharm Biomed Anal; 2015 Oct; 114():88-96. PubMed ID: 26026267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acid-base titrimetry in non-aqueous solvents. Applications to drug analysis].
    Molle L
    J Pharm Belg; 1968; 23(11):527-86. PubMed ID: 5732256
    [No Abstract]   [Full Text] [Related]  

  • 34. Computational approaches to determine drug solubility.
    Faller B; Ertl P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):533-45. PubMed ID: 17588703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of drug precipitation upon dilution of pH-controlled formulations.
    Narazaki R; Sanghvi R; Yalkowsky SH
    Mol Pharm; 2007; 4(4):550-5. PubMed ID: 17530775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
    Kalogeras IM
    Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and computational screening models for prediction of aqueous drug solubility.
    Bergström CA; Norinder U; Luthman K; Artursson P
    Pharm Res; 2002 Feb; 19(2):182-8. PubMed ID: 11885560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Miniaturization of powder dissolution measurement and estimation of particle size.
    Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
    Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.